KELIX Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 8

KELIX Bio General Information

Description

Manufacturer of specialty generic pharmaceutical products focused on introducing generic medicines. The company offers oncology, anti-infective, cardiovascular, and critical-care treatments through integrated development, manufacturing, and commercialization capabilities, enabling healthcare providers and patients in underserved markets to access pharmaceuticals.

Contact Information

Formerly Known As
Zanzibar Pharma
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 206 and 207, Level 2
  • Gate Village 10
  • Dubai United Arab Emirates
Primary Industry
Pharmaceuticals
Other Industries
Holding Companies
Drug Discovery
Corporate Office
  • 206 and 207, Level 2
  • Gate Village 10
  • Dubai United Arab Emirates

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KELIX Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KELIX Bio‘s full profile, request access.

Request a free trial

KELIX Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KELIX Bio‘s full profile, request access.

Request a free trial

KELIX Bio Investments & Acquisitions (8)

KELIX Bio’s most recent deal was a Buyout/LBO with DiabTec. The deal was made on 19-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DiabTec 19-Dec-2024 Buyout/LBO Other Devices and Supplies
Bioventure (Drug Discovery) 14-Oct-2024 Buyout/LBO Drug Discovery
Bioventure Healthcare 14-Oct-2024 Buyout/LBO BPO/Outsource Services
Gulf Inject 14-Oct-2024 Buyout/LBO Pharmaceuticals
WellPharma Medical Solutions 14-Oct-2024 Buyout/LBO Pharmaceuticals
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

KELIX Bio Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
WellPharma Medical Solutions Abu Dhabi, United Arab Emirates 2010
Celon Labs Hyderabad, India 2007
Gulf Inject Dubai, United Arab Emirates 1994
Bioventure Healthcare Dubai, United Arab Emirates
Bioventure (Drug Discovery) Dubai, United Arab Emirates

KELIX Bio FAQs

  • When was KELIX Bio founded?

    KELIX Bio was founded in 2020.

  • Where is KELIX Bio headquartered?

    KELIX Bio is headquartered in Dubai, United Arab Emirates.

  • What industry is KELIX Bio in?

    KELIX Bio’s primary industry is Pharmaceuticals.

  • Is KELIX Bio a private or public company?

    KELIX Bio is a Private company.

  • What is KELIX Bio’s current revenue?

    The current revenue for KELIX Bio is .

  • How much funding has KELIX Bio raised over time?

    KELIX Bio has raised $331M.

  • Who are KELIX Bio’s investors?

    Mubadala Investment Company has invested in KELIX Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process